Genomic stability prevails in North-African hepatocellular carcinomas
- 作者P. Pineau; S. Ezzikouri; A. Marchio; M. Benazzouz; E. Cordina; R. Afifi; L. Elkihal; M.T. Khalfallah; H. Mestiri; S. Tebbal; S. Berkane; N. Debzi; H. Triki; A. Dejean; F. Iguer; O. Bahri; A.E.E. Essaid el Feydi; S. Benjelloun
- 卷第39卷
- 期第7期
- 文件大小442.74KB
- 发表时间2007
- DOI10.1016/j.dld.2007.03.012
- 页码671-677
Reply to Tuomela's Reply to My ReplyWettersten, J. · Philosophy of the Social Sciences · 2012
"Heathen or Celt First: A Reply" (A Reply to Reply)Aidan · The Irish Monthly · 1925
Reply to Parsons, Reply to Heller, and Reply to ReaHUD HUDSON · 2008
Reply: Reply to Oluf Anderson's Reply: Predicting a window of therapeutic opportunity in multiple sclerosisAndersen, O. · Brain · 2011
Reply to Dr. Bagasra's replyGerard Gallacher · 1994
Reply to the replyHendrik Harssema · 1981
A Reply To A ReplyAlec Nove · 1977
Reply to Ken Smith's replyJane Elliott; Shirley Dex · 2009
Pancreatic ductal abnormalities by secretin-MRCP in asymptomatic subjects with chronic pancreatic hyperenzymemiaA. Mariani; B. Mangiavillano; S. Curioni; A. Giussani; E. Masci; P.A. Testoni · 2006
Secretin-MRCP guided diagnostic/therapeutic algorithm in recurrent idiopathic pancreatitis: Results on medium term follow-upA. Mariani; M. Rossi; S. Curioni; E. Masci; P.A. Testoni · 2001
Frequency of post-ERCP pancreatitis in a single tertiary referral centre without and with routine prophylaxis with gabexate: A 6-year survey and cost-effectiveness analysisP.A. Testoni; A. Mariani; E. Masci; S. Curioni · 2006